How to Implement a Hybrid Clinical Trial Model

Hybrid clinical trials give sponsors and CROs the flexibility to combine traditional site-based research with decentralized activities that participants can complete from home or wherever is most convenient. Done well, the model can reduce unnecessary travel and participant burden while maintaining the site involvement required for complex clinical research.

The challenge is making those experiences work together. A hybrid trial should not feel like a site-based study with disconnected digital tools added on top. It requires a coordinated approach to study design, data collection, participant engagement, site workflows, and technology.

THREAD's configurable no-code clinical research platform is designed to support remote, hybrid, and fully decentralized clinical trials within a single technology environment, with capabilities spanning eConsent, eCOA, eDiaries, eCRFs, digital health technologies, virtual visits, engagement, integrations, reporting, and real-time analytics.

Here are the key steps for putting that hybrid model into practice.

1. Determine What Should Happen at the Site—and What Doesn't Have To

A hybrid study should start with the protocol rather than the technology.

Review each participant interaction and determine whether it truly requires an in-person site visit. Procedures such as imaging, infusions, physical examinations, or certain sample collections may remain site-based, while questionnaires, diaries, follow-up conversations, education, some consent activities, and digital health technology data collection may be appropriate for remote completion.

THREAD's no-code configuration allows study teams to design workflows around those requirements instead of forcing a protocol into a fixed technology model. Different schedules, forms, assessments, notifications, and participant pathways can be configured within the platform, allowing the site-based and decentralized components of a study to function as one experience.

The objective is not to decentralize everything. It is to decentralize the activities where doing so can make participation easier without compromising study requirements.

2. Give Participants One Digital Entry Point Into the Study

Once remote activities have been identified, participants need a simple way to understand what they need to do and when they need to do it.

The THREAD Participant App brings study activities into one participant-facing experience. Participants can contribute data, answer surveys, conduct virtual visits, access educational materials, track upcoming activities, review progress, and receive reminders.

This is particularly valuable in a hybrid trial because the participant relationship with the study continues between site visits. Instead of relying entirely on site staff to remind participants about upcoming assessments or follow up on missed activities, digital touchpoints can become part of the study workflow.

THREAD also supports BYOD or provisioned devices, smart reminders, offline data capture, engagement tools, and integrations with wearables and sensors, giving teams flexibility in how participants interact with the study.

3. Move Appropriate Assessments Out of the Clinic

Electronic clinical outcome assessments are one of the most practical ways to introduce a hybrid model.

Using THREAD eCOA and eDiaries, participants can complete appropriate patient-reported, clinician-reported, or caregiver-reported assessments electronically rather than requiring every data collection event to coincide with an in-person visit.

This can help sponsors capture information closer to the participant's real-world experience while reducing dependence on scheduled site encounters. THREAD can also integrate into an existing clinical technology ecosystem, allowing sponsors to introduce eCOA without necessarily replacing every other system being used in the trial.

That modularity is important when implementing hybrid models incrementally: sponsors can add decentralized functionality where it provides value without changing every established study workflow at once.

4. Replace Unnecessary Travel with Virtual Visits

Not every interaction between participants and sites requires both parties to be physically in the same location.

THREAD supports telehealth screening, enrollment, and virtual visits through its participant-facing application and site-facing web portal. Investigators and coordinators can remotely interact with participants while remaining connected to the broader study workflow.

For appropriate protocol activities, virtual visits can provide continuity between in-person appointments while reducing participant travel. They can also give sites another way to maintain the personal interaction that remains critical to participant support and retention.

Hybrid research therefore does not have to mean less connection with participants. It can mean providing more flexible ways for that connection to happen.

5. Extend Data Collection into Participants' Daily Lives

Hybrid trials create opportunities to collect data beyond episodic site visits.

THREAD supports digital health technologies alongside eCOA, eDiaries, eCRFs and eSource, voice, image and video capture, and other methods of data collection. APIs and integrations can connect additional technologies and data sources into the study ecosystem.

Wearables, sensors, and other digital health technologies can be particularly useful when continuous or longitudinal measurements are meaningful to the protocol. Rather than asking participants to change technologies simply to participate in research, an integration strategy can help connect appropriate devices and systems into the study.

The result is a more continuous model of research in which data can be collected at the site, remotely, or passively depending on the requirements of the study.

6. Build Engagement and Retention Into the Workflow

Moving activities away from the site creates flexibility, but it also makes proactive engagement essential.

THREAD supports automated notifications, protocol-specific reminders, and mobile-accessible workflows intended to reduce friction and help participants remain aligned with study requirements. Real-time visibility into participant activity and configurable alerts can also help research teams identify signs of disengagement and follow up before they result in study drop-off.

This creates a feedback loop between participant convenience and study oversight. Participants receive clear information about what they need to complete, while sites and study teams gain visibility into activity between visits.

Features that can be configured into a hybrid engagement strategy include automated reminders and notifications, mobile study activities, eCOA and eDiaries, virtual visits, participant education, digital health technology collection, configurable alerts, and real-time reporting.

The result is not simply more communication. It is communication and engagement built around the protocol and triggered when it is most useful.

7. Keep Sites at the Center of the Hybrid Model

Decentralization should not create additional complexity for sites.

THREAD's site-facing tools provide remote access to participant profiles, eCRFs, study data, queries, virtual visits, and other trial activities. Principal investigators, study coordinators, and other authorized research team members can access study workflows through a web-enabled portal.

A successful hybrid model should therefore consider site workflows at the same time participant workflows are designed. Remote data collection should decrease unnecessary manual work rather than create another system that sites need to monitor independently.

Connecting participant activities, study data, alerts, and site oversight within the same platform can help make decentralized components an extension of the site's workflow rather than a parallel process.

8. Connect the Rest of the Clinical Technology Ecosystem

Most clinical trials already depend on multiple systems. Implementing a hybrid model does not necessarily mean replacing all of them.

THREAD supports APIs and integrations so decentralized capabilities can connect with the broader study technology ecosystem. Its stand-alone eCOA approach, for example, is designed to integrate with systems already selected for a study rather than requiring sponsors to change everything at once.
That approach can make hybrid implementation more practical. Sponsors can determine where THREAD should act as the primary platform and where it should integrate with existing clinical systems, devices, or data sources.

9. Use Real-Time Data to Manage the Study Proactively

Moving activities beyond research sites makes visibility especially important.

THREAD provides configurable reporting and real-time analytics alongside its participant, site, and data-capture capabilities. In a hybrid model, this gives study teams an opportunity to monitor participation and execution without depending entirely on scheduled visits to understand what is happening.

For example, teams can identify missed participant activities, monitor completion patterns, review incoming data, and determine when site intervention may be required.

Instead of simply digitizing individual trial activities, the goal is to create a connected operational picture across site-based and remote study execution.

10. Transition an Active Site-Based Study to a Hybrid Model

Hybrid implementation does not always have to begin before first patient in.

An active site-based study may already be experiencing participant burden, retention challenges, fragmented technologies, or workflows that would benefit from decentralized capabilities. Historically, sponsors have often been hesitant to change technology once a trial is underway because of the potential disruption to sites, participants, and existing data.

THREAD's Rapid Migration capabilities provide another option.

THREAD can transition active clinical trials from legacy technologies while maintaining study continuity. The platform can start participants at their current point in the study journey, accept and process data from legacy or partner systems, preserve a complete audit trail, and enable continuity without downtime for research sites, participants, or study teams. THREAD reported in October 2025 that these capabilities had already been used to process and move more than 1.2 million participant records from active global studies.

Once an active trial is transitioned, sponsors can evaluate where appropriate hybrid capabilities—such as remote eCOA, mobile reminders, virtual visits, digital health technologies, and participant engagement workflows—can enhance the remaining study experience.

That creates an important distinction: moving to a hybrid model does not always require starting over. It can be a way to modernize an existing study while maintaining continuity.

Build Hybrid Around the Participant and Protocol

There is no single hybrid clinical trial model that is right for every study.

A rare disease trial may prioritize minimizing long-distance travel. A Phase 3 study may need to preserve substantial site involvement while moving frequent questionnaires into participants' homes. A post-approval study may rely heavily on remote data collection and digital engagement over several years.

The technology needs to flex around those differences.

THREAD combines configurable no-code workflows with participant engagement, eCOA, telehealth, digital health technology, data capture, integrations, analytics, and consulting support to enable sponsors and CROs to determine the right balance of site-based and decentralized research for each protocol.

The most effective hybrid clinical trials are not defined by how many activities happen remotely. They are defined by how effectively every part of the study works together.

By designing around the participant journey, preserving appropriate site involvement, connecting data and technology, and using real-time engagement capabilities, sponsors can build hybrid studies that reduce unnecessary burden while maintaining the operational control and data quality required for clinical research.

Ready to design a hybrid clinical trial—or add decentralized capabilities to an active study? Explore how THREAD's configurable clinical research platform can help your team design, launch, migrate, and operate a more flexible, patient-centered research experience.